ADAMTS13 and thrombotic thrombocytopenic purpura: In a cohort of 17 patients with probable iTTP (low ADAMTS13 activity associated with the presence of ADAMTS13 inhibitors and/or favorable response after immunotherapy), none had all five TTP features.